Should targeted temperature management be used in cardiogenic shock patients? Systematic review and meta-analysis

CONCLUSIONS: The present analysis shows no significant benefit of TTM in patients with CS. Moreover, no statistically significant increase of the incidence of adverse effects was found. However, further randomized studies with higher sample size and greater validity are needed to determine if TTM is worth implementing in CS patients.PMID:36200546 | DOI:10.5603/CJ.a2022.0093

Source: Cardiology Journal - October 6, 2022 Category: Cardiology Authors: Adam Nieborek Jerzy R Ladny Milosz J Jaguszewski Andrea Denegri Aleksandra Sikora Szymon Pucylo Aleksandra Gasecka Michal Pruc Ivan Savytsky Lukasz Szarpak Source Type: research